Skip to content

EUROIMMUN Medizinische Labordiagnostika AG

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2020

    EUROIMMUN launches quantitative SARS-CoV-2 antibody test

    EUROIMMUN launched the Anti-SARS-CoV-2 QuantiVac ELISA (IgG), a quantitative test to measure IgG antibodies against the SARS-CoV-2 S1 antigen. The assay is available in countries accepting the CE mark; the company planned to seek U.S. FDA Emergency Use Authorization.